Medartis Holding AG
Medartis Holding AG, a medical device company, engages in the development, manufacturing, and sales of implant solutions worldwide. The company's medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. It provides osteosynthesis products for the hand, wrist, forearm, elbow, shoulder, and fo… Read more
Medartis Holding AG (MDRSF) - Total Liabilities
Latest total liabilities as of June 2025: $204.50 Million USD
Based on the latest financial reports, Medartis Holding AG (MDRSF) has total liabilities worth $204.50 Million USD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Medartis Holding AG - Total Liabilities Trend (2014–2024)
This chart illustrates how Medartis Holding AG's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Medartis Holding AG Competitors by Total Liabilities
The table below lists competitors of Medartis Holding AG ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Abcellera Biologics Inc
NASDAQ:ABCL
|
USA | $215.59 Million |
|
Taiflex Scientific Co Ltd
TW:8039
|
Taiwan | NT$3.85 Billion |
|
Ratos AB (publ)
PINK:RTOBF
|
USA | $13.99 Billion |
|
Hanmi Financial Corporation
NASDAQ:HAFC
|
USA | $7.07 Billion |
|
Aecon Group Inc
PINK:AEGXF
|
USA | $3.06 Billion |
|
WHA Premium Growth Freehold And Leasehold Real Estate Investment Trust
BK:WHART
|
Thailand | ฿17.88 Billion |
|
LegalZoom.com Inc
NASDAQ:LZ
|
USA | $359.03 Million |
|
Cartesian Growth Corporation II Warrant
NASDAQ:RENEW
|
USA | $22.68 Million |
Liability Composition Analysis (2014–2024)
This chart breaks down Medartis Holding AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.31 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.78 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.44 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Medartis Holding AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Medartis Holding AG (2014–2024)
The table below shows the annual total liabilities of Medartis Holding AG from 2014 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $190.31 Million | +101.23% |
| 2023-12-31 | $94.58 Million | +4.95% |
| 2022-12-31 | $90.11 Million | +21.47% |
| 2021-12-31 | $74.18 Million | +6.35% |
| 2020-12-31 | $69.76 Million | -4.36% |
| 2019-12-31 | $72.94 Million | +94.13% |
| 2018-12-31 | $37.57 Million | -66.88% |
| 2017-12-31 | $113.45 Million | +15.60% |
| 2016-12-31 | $98.14 Million | -34.56% |
| 2015-12-31 | $149.97 Million | -1.51% |
| 2014-12-31 | $152.28 Million | -- |